Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.45 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2949926 | 0.85 | MAPK1 (0.47) | ALDH1A1MAOBMAPK1L3MBTL1LMNA | |
| SCHEMBL2206253 | 0.84 | ALDH1A1 (0.48) | ALDH1A1MAOBMAPK1LMNARAB9A | |
| SCHEMBL6805430 | 0.84 | L3MBTL1 (0.57) | ALDH1A1MAPK1L3MBTL1LMNA | |
| SCHEMBL28138968 | 0.83 | ALB (0.45) | ALDH1A1MAPK1L3MBTL1LMNARAB9A | |
| SCHEMBL11205828 | 0.83 | RIPK1 (0.46) | ALDH1A1MAOBL3MBTL1KDM4ERIPK1 | |
| SCHEMBL4661911 | 0.82 | ALDH1A1 (0.51) | ALDH1A1MAPK1IDO1LMNARAB9A | |
| SCHEMBL6969660 | 0.82 | ALDH1A1 (0.51) | ALDH1A1MAPK1IDO1LMNARAB9A | |
| SCHEMBL435759 | 0.82 | TAAR1 (0.48) | ALDH1A1MAOBMAPK1IDO1LMNA | |
| SCHEMBL28357376 | 0.82 | ANO1 (0.47) | ALDH1A1MAOBMAPK1L3MBTL1KDM4E | |
| SCHEMBL9102212 | 0.82 | P2RX7 (0.45) | ALDH1A1MAOBL3MBTL1RAB9ARIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115219637-B | Method for analyzing flavor substances and mouthfeel and taste of salty fresh seasoning | 广州城市职业学院 | 2023-10-20 | — | — | CN | claimed |
| CN-114950159-B | Preparation method of aromatic polymer separation membrane based on super acid catalysis | 南京工业大学 | 2023-06-06 | — | — | CN | claimed |
| CN-116082203-A | Shulin acid intermediate impurity and preparation method thereof | 宁波大红鹰药业股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-114094098-A | Metal lithium powder composite material, preparation method, silica cathode and lithium ion battery | 上海卡耐新能源有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-104710256-A | Cheap and efficient synthesis method of alpha-hydroxyketone compound | UNIV BEIJING | 2015-06-17 | — | — | CN | claimed |
| CN-101891569-B | Preparation method of alpha-aromatic ketone compound | UNIV WUHAN | 2013-07-24 | — | — | CN | claimed |
| EP-2499147-A2 | IMPROVED PROCESSES FOR PREPARING PRASUGREL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEROEOF | MSN Laboratories Limited (IN) | 2012-09-19 | — | — | EP | claimed |
| US-20120202066-A1 | Processes For Preparing Prasugrel And Pharmaceutically Acceptable Salts Thereof | MSN LABORATORIES LIMITED (IN) | 2012-08-09 | — | — | US | claimed |
| WO-2011042918-A2 | NOVEL AND IMPROVED PROCESSES FOR THE PREPARATION OF PRASUGREL, ITS INTERMEDIATES AND PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES LIMITED (IN) | 2011-04-14 | — | — | WO | claimed |
| CN-101429193-A | Process for producing 1-tetrahydropyran-3-methyl-5-amido indazole | UNIV NANCHANG HANGKONG (CN) | 2009-05-13 | — | — | CN | claimed |
| EP-4665738-A1 | MIXED P,N-DONOR LIGANDS, THEIR COMPLEXES AND USE THEREOF | Umicore AG & Co. KG (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-20250381187-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC. (US) | 2025-12-18 | — | — | US | disclosed |
| US-12440491-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250049036-A1 | SUBSTITUTED FUSED BICYCLIC PYRIDINE CARBOXAMIDE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | PI INDUSTRIES LTD. (IN) | 2025-02-13 | — | — | US | disclosed |
| CN-119040289-A | Amine dehydrogenase and encoding nucleic acid and application thereof | 河北工业大学 | 2024-11-29 | — | — | CN | disclosed |
| WO-1994024098-A1 | Ξ-FLUOROSULPHONIMIDES, METHOD OF PREPARING THEM AND THEIR USE AS FLUORINATION AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-10-27 | — | — | WO | disclosed |
| US-5288726-A | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | UBE INDUSTRIES LIMITED (JP) | 1994-02-22 | — | — | US | disclosed |
| EP-0542411-A2 | Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation | Sankyo Company Limited (JP) | 1993-05-19 | — | — | EP | disclosed |
| EP-0200942-A2 | New derivatives of an aminoketone | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1986-11-12 | — | — | EP | disclosed |
| US-3998971-A | Novel N-vinyloxyethyl-α-methyl-β-phenethylamines for depressing appetite | ABBOTT LABORATORIES (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049036-A1 | SUBSTITUTED FUSED BICYCLIC PYRIDINE CARBOXAMIDE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | CBR3, C5, CBR1 | ALDH1A1 3438/4885MAOB 602/4885MAPK1 1510/4885 |
| US-20250381187-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | KRAS, NRAS, HRAS | ALDH1A1 4162/4885MAOB 4809/4885MAPK1 1073/4885 |
| US-12440491-B2 | KRAS G12C inhibitors and methods of using the same | KRAS, NRAS, HRAS | ALDH1A1 4162/4885MAOB 4809/4885MAPK1 1073/4885 |
| US-20120202066-A1 | Processes For Preparing Prasugrel And Pharmaceutically Acceptable Salts Thereof | SF1, PFKP, CYP2F1 | ALDH1A1 340/4885MAOB 2182/4885MAPK1 507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.